The development of PCR based assays for the detection and differentiation of simian immunodeficiency virus in vivo.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Virological Methods

• Publication date

  1995-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0166-0934(94)00109-TPMID 7738143
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Polymerase Chain Reaction

  2019cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants.

  1994cited by this paper
• An international collaborative study to assess a set of reference reagents for HIV-1 PCR.

  1992cited by this paper
• Population Sequence Analysis of a Simian Immunodeficiency Virus (32H Reisolate of SIVmac251): A Virus Stock Used for International Vaccine Studies

  1992cited by this paper
• Production and of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins.

  1991cited by this paper
• The use of the polymerase chain reaction for the detection of Simian immunodeficiency virus in experimentally infected macaques.

  1990cited by this paper
• Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine

  1990cited by this paper
• Clinical Applications of the Polymerase Chain Reaction

  1990cited by this paper
• Animal models in AIDS

  1990cited by this paper
• A simple high-resolution procedure to study DNA methylation and in vivo DNA-protein interactions on a single-copy gene level in higher eukaryotes.

  1989cited by this paper
• Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses

  1987cited by this paper
• Restricted expression of human T-cell leukemia--lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes.

  1983cited by this paper

• Complement-Mediated Virus Infectivity Neutralisation by HLA Antibodies Is Associated with Sterilising Immunity to SIV Challenge in the Macaque Model for HIV/AIDS

  2014influential citation
• Neuropathology of wild-type and nef-attenuated T cell tropic simian immunodeficiency virus (SIVmac32H) and macrophage tropic neurovirulent SIVmac17E-Fr in cynomolgus macaques

  2012cites this paper
• Low rates of transmission of SRV‐2 and STLV‐I to juveniles in a population of Macaca fascicularis facilitate establishment of specific retrovirus‐free colonies

  2009cites this paper
• Limited dissemination of pathogenic SIV after vaginal challenge of rhesus monkeys immunized with a live, attenuated lentivirus.

  2009cites this paper
• The Mhc class II DRB genotype of Macaca fascicularis does not influence infection by simian retrovirus type 2.

  2008cites this paper
• Resistance to superinfection by a vigorously replicating, uncloned stock of simian immunodeficiency virus (SIVmac251) stimulates replication of a live attenuated virus vaccine (SIVmacC8).

  2008cites this paper
• Preparation and characterization of new challenge stocks of SIVmac32H J5 following rapid serial passage of virus in vivo

  2007cites this paper
• CD 8 Lymphocytes Do Not Mediate Protection against Acute Superinfection 20 Days after Vaccination with a Live Attenuated Simian Immunodeficiency Virus

  2005cites this paper
• CD8+ Lymphocytes Do Not Mediate Protection against Acute Superinfection 20 Days after Vaccination with a Live Attenuated Simian Immunodeficiency Virus

  2005cites this paper
• Vaccination with live attenuated simian immunodeficiency virus for 21 days protects against superinfection.

  2004cites this paper
• Persistence and Dissemination of Simian Retrovirus Type 2 DNA in Relation to Viremia, Seroresponse, and Experimental Transmissibility in Macaca fascicularis

  2003cites this paper
• Mechanisms of protection induced by attenuated simian immunodeficiency virus.

  2002cites this paper
• In situ hybridization and immunolabelling study of the early replication of simian immunodeficiency virus (SIVmacJ5) in vivo.

  2001cites this paper
• Mechanisms of protection induced by live attenuated simian immunodeficiency virus

  2001cites this paper
• Specific Proliferative T Cell Responses and Antibodies Elicited by Vaccination with Simian Immunodeficiency Virus Nef Do Not Confer Protection against Virus Challenge

  2001cites this paper
• Up‐regulation of β‐chemokines and down‐modulation of CCR5 co‐receptors inhibit simian immunodeficiency virus transmission in non‐human primates

  2000cites this paper
• The appearance of escape variants in vivo does not account for the failure of recombinant envelope vaccines to protect against simian immunodeficiency virus.

  1999cites this paper
• Detection of bovine retrospumavirus by the polymerase chain reaction.

  1999cites this paper
• Monoclonal Antibodies Recognize at Least Five Epitopes on the SIV Nef Protein and Identify an in Vitro-Induced Mutation

  1999cites this paper
• Long-lasting protection by live attenuated simian immunodeficiency virus in cynomolgus monkeys: no detection of reactivation after stimulation with a recall antigen.

  1999cites this paper
• Progressive dendritic pathology in cynomolgus macaques infected with simian immunodeficiency virus

  1999cites this paper
• In vivo resistance to simian immunodeficiency virus superinfection depends on attenuated virus dose.

  1998cites this paper
• Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm

  1998cites this paper
• Evaluation of a candidate human immunodeficiency virus type 1 (HIV-1) vaccine in macaques: effect of vaccination with HIV-1 gp120 on subsequent challenge with heterologous simian immunodeficiency virus-HIV-1 chimeric virus.

  1998cites this paper
• Protective mucosal immunity elicited by targeted lymph node immunization with a subunit SIV envelope and core vaccine in macaques.

  1998cites this paper
• Mechanisms of Protection Induced by Attenuated Simian Immunodeficiency Virus II. Lymphocyte Depletion Does Not Abrogate Protection

  1998cites this paper
• Mechanisms of protection induced by attenuated simian immunodeficiency virus. I. Protection cannot be transferred with immune serum.

  1997cites this paper
• Mechanisms of protection induced by attenuated simian immunodeficiency virus. IV. Protection against challenge with virus grown in autologous simian cells

  1997cites this paper
• Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys.

  1997cites this paper
• Macaques infected with attenuated simian immunodeficiency virus resist superinfection with virulence-revertant virus.

  1997cites this paper
• Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa.

  1997cites this paper
• The Construction and Evaluation of SIV/HIV Chimeras That Express the Envelope of European HIV Type 1 Isolates

  1997cites this paper
• Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques

  1996cites this paper
• Use of the polymerase chain reaction to screen cell banks for retroviruses.

  1996cites this paper
• Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence

  1995cites this paper
• Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.

  1995cites this paper
• Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques

  1995cites this paper
• V-2 Nov 95

  year unknowncites this paper